Browse > Article
http://dx.doi.org/10.9721/KJFST.2021.53.6.715

Effect of 1,2,3,4,6-penta-O-gallolyl-β-ᴅ-glucose on markers of cognitive function in human neuroblastoma SK-N-SH cell line  

Yoon, Hyeon Seok (Department of Food and Nutrition, Daegu University)
Park, So Yeon (Department of Food and Nutrition, Daegu University)
Kim, Yoon Hee (Department of Food and Nutrition, Daegu University)
Publication Information
Korean Journal of Food Science and Technology / v.53, no.6, 2021 , pp. 715-721 More about this Journal
Abstract
Cognitive impairment and Alzheimer's disease are serious social problems associated with the rising elderly population in Korea. 1,2,3,4,6-Penta-O-galloyl-β-ᴅ-glucopyranose (PGG) is a gallotannin isolated from medicinal plants such as Rhus chinensis. This study was performed to evaluate the effect of PGG on biomarkers related to cognitive function in human neuroblastoma SK-N-SH cells. Inhibition of acetylcholinesterase (AChE) activity is considered to be one of the main therapeutic strategies. PGG inhibited AChE activity in the test tube as well as in SK-N-SH cells. In addition, PGG induced protein and mRNA expression of brain-derived neurotrophic factor (BDNF), which is a mammalian neurotrophin that plays major roles in the development, maintenance, repair, and survival of neuronal populations. As one of the underlying molecular mechanisms that induce BDNF expression, PGG induced the activation of Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII)-cAMP response element binding protein (CREB) pathway. In conclusion, PGG may be an useful material for improving cognitive function.
Keywords
penta galloyl glucose; tannin; acetylcholineesterase; brain-derived neurotophic factor; cognitive function;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Mendonca P, Taka E, Bauer D, Cobourne-Duval M, Soliman KF. The attenuating effects of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose on inflammatory cytokines release from activated BV-2 microglial cells. J. Neuroimmunol. 15: 9-15 (2017)
2 Ren Y, Himmeldirk K, Chen X. Synthesis and structure-activity relationship study of antidiabetic penta-O-galloyl-D-glucopyranose and its analogues. J Med. Chem. 49: 2829-2837 (2006)   DOI
3 Abhijit D, Raktim B, Anuradha M, Devendra KP. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions. Biotechnol. Adv. 35: 178-216 (2017)   DOI
4 Bekinschtein P, Cammarota M, Igaz LM, Bevilaqua LR, Izquierdo I, Medina JH. Persistence of long-term memory storage requires a late protein synthesis and BDNF-dependent phase in the hippocampus. Neuron. 53: 261-277 (2007)   DOI
5 Tu Z, Gong W, Zhang Y, Feng Y, Liu Y, Tu C. Inhibition of Rabies virus by 1,2,3,4,6-penta-O-galloyl-beta-d-glucose involves mTOR-dependent autophagy. Viruses 10: 201 (2018)   DOI
6 Wang Y, Yin F, Guo H, Zhang J, Yan P, Lai J. The Role of Dopamine D1 and D3 Receptors in N-Methyl-D-Aspartate (NMDA)/ GlycineB Site-Regulated Complex Cognitive Behaviors following Repeated Morphine Administration. Int. J. Neuropsychopharmacol. 20: 562-574 (2017)   DOI
7 Araki S, Osuka K, Takata T, Tsuchiya Y, Watanabe Y. Coordination between Calcium/Calmodulin-Dependent Protein Kinase II and Neuronal Nitric Oxide Synthase in Neurons. Int. J. Mol. Sci. 21: 7997 (2020)   DOI
8 Barbacid M. Neurotrophic factors and their receptors. Curr. Opin. Cell Biol. 7: 148-155 (1995)   DOI
9 Baek H, Chang GT, Kim JH. Experimental study on the effects of Bohyulanshin-tang on brain-derived neurotophic factor expression in SK-N-SH cell line. J. Physiol. Pathol. in Korean Med. 2: 139-145 (2005)
10 Bruno LG, Janine D, Hans CK, Rudi AJOD, Elke B, Erik FJV. Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation. Mol. Neurobiol. 56: 3295-3312 (2019)   DOI
11 Briggs R, Kennelly SP, O'Neill D. Drug treatments in Alzheimer's disease. Clin. Med (Lond). 16: 247-253 (2016)   DOI
12 Chen S, Jiang H, Liu Y, Hou Z, Yue Y, Zhang Y, et al. Combined serum levels of multiple proteins in tPA-BDNF pathway may aid the diagnosis of five mental disorders. Sci. Rep. 7: 6871 (2017)   DOI
13 Corpuz HM, Fujii H, Nakamura S, Katayama S. Fermented rice peptides attenuate scopolamine-induced memory impairment in mice by regulating neurotrophic signaling pathways in the hippocampus. Brain Res. 1720: 146322 (2019)   DOI
14 Fujiwara H, Tabuchi M, Yamaguchi T, Iwasaki K, Furukawa K, Sekiguchi K, et al. A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose have potent anti-aggregation effects on Alzheimer's amyloid beta proteins in vitro and in vivo. J. Neurochem. 109: 1648-1657 (2009)   DOI
15 Guo XX, He QZ, Li W, Long DX, Pan XY, Chen C, et al. Brain-derived neurotrophic factor mediated perfluorooctane sulfonate induced-neurotoxicity via epigenetics regulation in SK-N-SH cells. Int. J. Mol. Sci. 18: 893 (2017)   DOI
16 Kim YH, Im AR, Park BK, Paek SH, Choi G, Kim YR, et al. Anti-depressant-Like and Neuroprotective Effects of Ethanol Extract from the Root Bark of Hibiscus syriacus L. Biomed. Res. Int. 2018: 7383869 (2018)
17 Kandiah N, Pai MC, Senanarong V, Looi I, Ampil E, Park KW, et al. Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and parkinson's disease dementia. Clin. Interv. Aging. 12: 697-707 (2017)   DOI
18 Deogracias R, Espliguero G, Iglesias T, Rodriguez-Pena A. Expression of the neurotrophin receptor trkB is regulated by the cAMP/CREB pathway in neurons. Mol. Cell Neurosci. 26: 470-480 (2004)   DOI
19 Gold PW. The PPARg system in major depression: pathophysiologic and therapeutic implications. Int. J Mol. Sci. 22: 9248 (2021)   DOI
20 Jabril E, Gilbert Blaise. The role of acetylcholinesterase inhibitors such as neostigmine and rivastigmine on chronic pain and cognitive function in aging: A review of recent clinical applications. Alzheimers Dement (NY). 5: 175-183 (2019)   DOI
21 Lee HJ, Seong YH, Bae KH, Kwon SH, Kwak HM, Nho SK, et al. Beta-secretase (BACE1) inhibitors from Sanguisorbae Radix. Arch. Pharm. Res. 28: 799-803 (2005)   DOI
22 Lee HI, Gwak JY, Chung MJ. Inhibitory effects of Platycodon Grandiflorum, Codonopsis lanceolata, Corn Silk, and Acanthopanax senticosus against Nitric Oxide-Induced cytotoxicity in SK-N-SH Cells. J. Korean Soc. Food Sci. Nutr. 48: 823-832 (2019)   DOI
23 Lisman J, Yasuda R, Raghavachari S. Mechanisms of CaMKII action in long-term potentiation. Nat. Rev. Neurosci. 13: 169-182 (2012)   DOI
24 Dong Y, Yin S, Jiang C, Luo X, Guo X, Zhao C, et al. Involvement of autophagy induction in penta-1,2,3,4,6-O-galloyl-beta-D-glucose-induced senescence-like growth arrest in human cancer cells. Autophagy. 10: 296-310 (2014)   DOI
25 Health insurance review & assessment service. Available from: https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020041000100&brdScnBltNo=4&brdBltNo=10146&pageIndex=18. Accessed Sep. 21, 2020.
26 Luca CDA, Luisa S, Floriana V. Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. Int. J. Mol. Sci. 21: 7777 (2020)   DOI
27 Numakawa T, Odaka H, Adachi N. Action of brain-derived neurotrophin factor in the neurogenesis and neuronal function, and its involvement in the pathophysiology of brain diseases. Int. J. Mol. Sci. 19: 3650 (2018)   DOI
28 Patel SS, Raghuwanshi R, Masood M, Acharya A, Jain SK. Medicinal plants with acetylcholinesterase inhibitory activity. Rev. Neurosci. 29: 491-529 (2018)   DOI
29 Statistics Korea. 2020 Statistics on the Aged. Available from: http://kostat.go.kr/portal/eng/pressReleases/1/index.board?bmode=read&bSeq=&aSeq=388599&pageNo=10&rowNum=10&navCount=10&currPg=&searchInfo=&sTarget=title&sTxt=. Accessed Sep. 28, 2020.
30 Whang SG, Park HG. An analysis on prescribing patterns of alzheimer's dementia treatment and choline alfoscerate using HIRA claims data. Kor. J. Clin. Pharm. 29: 1-8 (2019)   DOI
31 Knight R, Khondoker M, Magill N, Stewart R, Landau S. A systematic review and meta-analysis of the effectiveness of acetylcholinesterase inhibitors and memantine in treating the cognitive symptoms of dementia. Dement. Geriatr. Cogn. Disord. 45: 131-151 (2018)   DOI